CO Hub for Health Impact

Congratulations to Fitzsimons Innovation Community CEO Steven VanNurden on exemplifying Colorado's collaborative, welcoming spirit and drive to innovate for patient health. Steve's incredible legacy includes supporting the growth of Colorado's life sciences community, growing Fitzsimons Innovation Community to more than 80 companies, and championing health innovation at the University of Colorado Anschutz Medical Campus, CU Innovations, and the CU Healthcare Innovation Fund. #COHubforHealthImpact #COLeadsLifeSciences?

Nothing like seeing a Colorado company's name on the big screen at the NYSE! Congratulations to the Enveda team on your $130M Series C. Our community celebrates your incredible journey to transform drug discovery. #COHubforHealthImpact #COLeadsLifeSciences

Colorado is the epicenter for health innovation! Congratulations and welcome to the team at RefinedScience. Thank you for choosing Colorado to continue your transformative work on precision drug development at Fitzsimons Innovation Community with support from CU Innovations. Our collaborative life sciences community is cheering for you! #COHubforHealthImpact #COLeadsLifeSciences

Innovation industries converge in Colorado. Our life sciences community collaborates with Colorado-based scientists and technologists revolutionizing quantum, climate tech, and aerospace.? #COHubforHealthImpact #COLeadsLifeSciences https://lnkd.in/exjNCUxt Colorado Office of Economic Development and International Trade

Colorado's life sciences community continues to grow because of strong fundraising, leading talent, continued investment in lab and office space, and outstanding support from academic and research institutions. Colorado's health innovators took center stage at the Denver Smart Business Dealmakers Conference, with Elyse Blazevich of Colorado BioScience Association, Kimberly Muller of CU Innovations, Afshin Safavi, Ph.D., of Colorado Health & Tech Centers, and Blake Unterreiner of Agilent Technologies highlighting Colorado's rise as a biotech and healthtech powerhouse. Congratulations?to the leaders honored at the event. Honorees from our life sciences community included:? Steven VanNurden, Fitzsimons Innovation Community? Scott Hutton, Biodesix, Inc.? Mark T. Lupa and Sally Hatcher, Buff Gold Ventures Kimberly Muller, CU Innovations? Elyse Blazevich, Colorado BioScience Association Mary Szela, TriSalus Life Sciences Why Colorado is a leading hub for health innovation:?https://lnkd.in/gt3iiyE8 #COHubforHealthImpact #COLeadsLifeSciences

An "only in Colorado" life sciences convergence. A toast to the Ambrosia Biosciences Inc. team on the honor of your own ale...along with your recent fundraising success! https://lnkd.in/gt3iiyE8 #COHubforHealthImpact #COLeadsLifeSciences

Sterling Bay develops design-driven projects that transform communities. Their newest innovation district, Redtail Ridge, brings next-generation research, medical care, and community to the high-tech U.S. 36 Corridor connecting Denver-Boulder. Rich in amenities, Redtail Ridge and its custom spaces for life sciences will grow and evolve with tenants. #COHubforHealthImpact #COLeadsLife Sciences More:?https://lnkd.in/gR4bDuZj

In Colorado, innovation industries converge. Life sciences, aerospace, climate technology, high technology, and quantum. Build the future here! https://lnkd.in/gt3iiyE8 #COHubforHealthImpact #COLeadsLifeSciences

Growing life sciences companies with diverse and complex lab needs scale in place at HATCHlabs @ Wilderness Place in Boulder. Offered by NexCore Group through the HATCHspaces ?platform, HATCHlabs @ Wilderness Place provides flexibility, faster setup, and a more cost-effective path for founders to realize their business goals. #COHubforHealthImpact #COLeadsLifeSciences More: https://lnkd.in/gCvapQSE

News - Colorado pharma startup Lohocla Research Corporation at Fitzsimons Innovation Community is recognized as a 2024 Colorado Inno Award Winner. The Colorado Inno Awards recognize trailblazers making waves in the Colorado innovation ecosystem and have plans to scale their work and impact next year. Lohocla Research received FDA clearance in March for the first-in-human trials of a drug, Nezavist, intended to treat alcohol use disorder and craving. The company also received similar FDA clearance in October 2023 to move forward with Phase 1 trials of a treatment for chronic pain. #COHubforHealthImpact #COLeadsLifeSciences https://lnkd.in/gUREmcT6